Table 1. Patient Characteristics.
| Variable | No. (%) | |
|---|---|---|
| Cisplatin, gemcitabine and berzosertib, Arm A | Cisplatin and gemcitabine Arm B | |
| No. | 46 | 41 |
| Age, median (range) | 67.5 (32-82) | 65 (32-84) |
| Sex | ||
| Male | 38 (83) | 30 (73) |
| Female | 8 (17) | 11 (27) |
| Race | ||
| White | 39 (85) | 35 (85) |
| Asian | 2 (4) | 1 (2) |
| Black/African American | 4 (9) | 3 (7) |
| Unknown | 1 (2) | 2 (5) |
| Ethnicity | ||
| Hispanic or Latino | 1 (2) | 1 (2) |
| Not Hispanic or Latino | 45 (98) | 38 (93) |
| Not reported/unknown | 0 (0) | 2 (5) |
| Visceral metastases | ||
| Yes | 22 (48) | 19 (46) |
| No | 24 (52) | 22 (54) |
| Bajorin risk group | ||
| 0 | 23 (50) | 22 (54) |
| 1 | 20 (43) | 19 (46) |
| 2 | 3 (7) | 0 (0.0) |
| Prior neoadjuvant cisplatin | ||
| Yes | 5 (11) | 4 (10) |
| No | 41 (89) | 37 (90) |